HHLR ADVISORS, LTD.
Institutional investor · Portfolio as of Q3 2020
Top Holdings89 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
ZOOM COMMUNICATIONS INC | 5M | $2.4B | 17.8% | $84.35 | +451.85% | 4 qtrssince 2019-Q4 | Decreased 0 |
BEIGENE LTD-ADR | 5.5M | $1.6B | 11.9% | $134.02 | +110.01% | 8 qtrssince 2018-Q4 | Unchanged 0 |
JD.COM INC-ADR | 16M | $1.2B | 9.4% | $44.76 | +52.36% | 8 qtrssince 2018-Q4 | Increased 100 |
ALIBABA GROUP HOLDING-SP ADR | 4M | $1.2B | 9.0% | $173.68 | +59.29% | 8 qtrssince 2018-Q4 | Increased 64 |
IQIYI INC | 39.3M | $887.4M | 6.7% | $18.39 | +23.97% | 8 qtrssince 2018-Q4 | Decreased 0 |
PDD HOLDINGS INC | 10.2M | $756.8M | 5.7% | $33.70 | +118.66% | 8 qtrssince 2018-Q4 | Increased 64 |
UBER TECHNOLOGIES INC | 19.3M | $702.6M | 5.3% | $29.72 | +19.22% | 5 qtrssince 2019-Q3 | Unchanged 0 |
CHINA BIOLOGIC PRODS HLDGS I | 3M | $329.2M | 2.5% | — | — | 8 qtrssince 2018-Q4 | Unchanged 0 |
TAL ED GROUP | 4.1M | $313.2M | 2.4% | $32.60 | +129.27% | 8 qtrssince 2018-Q4 | Decreased 0 |
KE HOLDINGS INC-ADR | 5M | $306.5M | 2.3% | $62.04 | 0.00% | 1 qtr | New 80 |
ENSTAR GROUP LIMITED | 1.7M | $282.3M | 2.1% | — | — | 7 qtrssince 2019-Q1 | Unchanged 0 |
GDS Holdings Ltd. Sponsored ADR Class A | 3.1M | $257.2M | 1.9% | $80.16 | 0.00% | 2 qtrssince 2020-Q2 | Increased 78 |
SALESFORCE.COM INC | 988,295 | $248.4M | 1.9% | $180.57 | +35.39% | 3 qtrssince 2020-Q1 | Increased 64 |
BRIDGEBIO PHARMA INC | 4.7M | $176.8M | 1.3% | $23.99 | +54.62% | 6 qtrssince 2019-Q2 | Unchanged 0 |
BILIBILI INC-SPONSORED ADR | 4M | $167.9M | 1.3% | $15.50 | +162.38% | 8 qtrssince 2018-Q4 | Decreased 0 |
Kyntra Bio, Inc. | 4M | $162.7M | 1.2% | — | — | — | — |
APELLIS PHARMACEUTICALS INC | 5M | $151.7M | 1.1% | $19.43 | +48.73% | 8 qtrssince 2018-Q4 | Unchanged 0 |
ALIGN TECHNOLOGY INC | 395,183 | $129.4M | 1.0% | $209.25 | +53.01% | 5 qtrssince 2019-Q3 | Decreased 0 |
MONDELEZ INTERNATIONAL INC-A | 2.2M | $127.8M | 1.0% | $33.70 | +46.97% | 8 qtrssince 2018-Q4 | Decreased 0 |
BLUEPRINT MEDICINES CORP | 1.4M | $126.5M | 1.0% | — | — | 8 qtrssince 2018-Q4 | Unchanged 0 |
HHLR ADVISORS, LTD. manages $13.2B across 89 positions as of Q3 2020. Top holdings: ZM (17.8%), ONC (11.9%), JD (9.4%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.
Active quarter - 20 new positions, 5 exits, 11 increased. Top move: JD (INCREASED, conviction 100). Portfolio: $13.2B across 89 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer